Skip to main content
. 2022 Jan 19;27(1-2):112–132. doi: 10.1007/s10495-021-01706-9

Fig. 4.

Fig. 4

Induction of hUsp27xL in WM1158 and 1205Lu leads to loss of cFLIPL protein and processing of caspase-8 when treated with pIC, but does not alter NF-κB or type I interferon signalling

A, B hUsp27xL induction decreases cFLIPL protein levels and increases caspase-8 processing upon pIC treatment. GFP-hUsp27xL doxycycline-inducible WM1158 (A) were pre-stimulated 48 h ± Dox to induce Usp27xL and afterwards QVD [10 µM] ± pIC was added for the indicated time points. 1205Lu cells inducibly expressing GFP-hUsp27xL (B) were stimulated for 48 h ± Dox, ± pIC at the same time as indicated. Cells were lysed in urea lysis buffer and proteins were analyzed by Western blot (for A, B: n = 3). C Quantification of cFLIPL protein levels detected by Western blotting (A, B) after 48 h dox treatment normalized to GAPDH. Shown are the cFLIPL protein levels relative to the untreated control (*: p value < 0.05, error bars represent SEM; n = 3). D Overexpression of hUsp27xL does not alter cFLIPL mRNA level. GFP-hUsp27xL doxycycline-inducible WM1158 and 1205Lu cells were treated or not with Dox the day after seeding and harvested at the indicated time points. The mRNA levels of cFLIPL and house-keeping genes (HPRT and GAPDH) were measured by qPCR. Obtained values were normalized to the respective uninduced cell-line. Error bars represent the geometric SD (ns: adjusted p value > 0.05); *: statistically significant = p-value < 0.05 (n = 3). E The loss of cFLIPL protein levels due to Usp27x overexpression is partially blocked by the addition of the proteasome inhibitor MG132. Western blot of WM1158-TetR-GFP-hUsp27xL cells unstimulated or pre-stimulated with Dox for 48 h to induce GFP-hUsp27xL, followed by ± treatment with MG132 [10 µM, 4 h]. cFLIPL protein levels were normalized to their GAPDH loading control and quantified against the untreated cells set to 100% (n = 2). F, B, Induction of hUsp27xL in WM1158 (F) or 1205Lu (B) cells does not alter the levels of NF-κB signal transduction proteins after pIC treatment. GFP-hUsp27xL doxycycline-inducible WM1158 cells were treated as described for A (n = 3). G Induction of hUsp27xL in WM1158 cells does not influence the TRL3 induced type I interferon signalling pathway under the same experimental setup used in (A, F). No change in TBK1, phospho-TBK1 nor phospho-IRF3 protein levels were detected, as well as total levels of upstream TRAF3 and TRIF (n = 3)